Sympatient was founded in 2016, rooted in the work of co-founder Julian Angern on VR-based anxiety therapy at the University Medical Center Schleswig-Holstein. The company works at the forefront of digital health care, actively shaping the future of psychotherapeutic care. Their team includes doctors, developers, and healthcare experts passionate about improving the treatment of mental illnesses.

Sympatient combines therapists and digital therapy to address the global mental health crisis. They believe modern therapy for mental illnesses must integrate the benefits of digital therapies with therapist sessions. Their Blended-Care approach makes psychotherapy accessible to all while ensuring individualized treatment. Sympatient offers unique digital therapeutics (DTx), such as Invirto®, the first digital anxiety therapy enabling patients with agoraphobia, social phobia, or panic disorder to undergo virtual reality exposure treatment combined with app-based cognitive behavioral therapy at home.

The company collaborates closely with therapists who can use Sympatient's DTx to optimize therapy or offer additional modules, while patients can also use the DTx independently after diagnosis. Their therapy is personalized through data-driven models tailored to individual patient needs.

Sympatient offers therapy for common mental health conditions and develops digital therapies to provide patients access to optimal care. Their services are reimbursed by statutory health insurance for 72 million insured individuals in Germany, offering immediate help without long waiting times, flexible treatment at the patient's own pace, and professional support through therapists.

Sympatient actively cooperates with leading institutions in Germany's healthcare system, including health insurers, clinics, practices, and patient associations, to shape the future network for mental healthcare.